Long-term outcome of systemic cyclosporine treatment following penetrating keratoplasty

Japanese Journal of Ophthalmology

Volumn 45, Issue 4, 2001, Pages 378-382

  Inoue, Kenji ^a   Kimura, Chikako ^a   Amano, Shiro ^a   Sato, Tsutomu ^a   Fujita, Natsuya ^a   Kagaya, Fumie ^a   Kaji, Yuichi ^a   Tsuru, Tadahiko ^b   Araie, Makoto ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cyclosporine; Graft survival; Penetrating keratoplasty; Rejection; Side effect

Indexed keywords

BETAMETHASONE; CYCLOSPORIN A; DEXAMETHASONE; PREDNISOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DRUG EFFICACY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; LIVER TOXICITY; LONG TERM CARE; MALE; NEPHROTOXICITY; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BLOOD UREA NITROGEN; CORNEA; CREATINE; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0034914930     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(01)00339-2     Document Type: Article

References (16)

1. The present status and future of keratoplasty in Japan
2. Update on topical cyclosporin A. Background, immunology, and pharmacology
3. FK506 and cyclosporine
4. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation
5. Conversion form standard cyclosporine to low-dose cyclosporine in liver transplant recipients; effect on nephrotoxicity and hypertension beyond one year
6. The use of cyclosporine in high-risk keratoplasty
7. Effect of oral cyclosporine in high-risk corneal transplantation
8. Effect of cyclosporine following penetrating keratoplasty
9. Transplantation and rejection of individual cell layers of the cornea
10. Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy
11. Successful engraftment of high-risk corneal allografts with short-term immunosuppression with cyclosporine
12. Systemic ciclosporin A in high-risk keratoplasties
13. Graft rejection developed in a case of penetrating keratoplasty during systemic cyclosporine therapy
14. Therapeutic use of topical cyclosporine
15. Topical cyclosporine in high-risk corneal transplants
16. Local therapy of corneal allograft rejection with cyclosporine